Relevant baseline clinical variables related to lack of good clinical response were hypertension (p = 0.08), hyperlipidaemia (p = 0.09), mineralocorticoid receptor inhibitor therapy (p = 0.06), and increasing levels of NT-proBNP (p = 0.22). Here, NR3C2 is linked to hyperlipidemia.